Total Payments
$8,355
2024 Payments
$2,440
Companies
46
Transactions
342
Medicare Patients
1,171
Medicare Billing
$571,291
Payment Breakdown by Category
Food & Beverage$8,348 (99.9%)
Education$6.80 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,348 | 341 | 99.9% |
| Education | $6.80 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,242 | 63 | $0 (2024) |
| Amgen Inc. | $1,017 | 33 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $878.42 | 38 | $0 (2024) |
| Corcept Therapeutics | $607.41 | 18 | $0 (2024) |
| Radius Health, Inc. | $595.56 | 24 | $0 (2024) |
| Lilly USA, LLC | $556.54 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $397.29 | 18 | $0 (2024) |
| Mannkind Corporation | $343.30 | 16 | $0 (2024) |
| BETA BIONICS, INC. | $267.66 | 3 | $0 (2024) |
| Antares Pharma, Inc. | $245.94 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,440 | 93 | Amgen Inc. ($442.05) |
| 2023 | $2,563 | 118 | Bayer Healthcare Pharmaceuticals Inc. ($351.25) |
| 2022 | $2,403 | 103 | Bayer HealthCare Pharmaceuticals Inc. ($362.90) |
| 2021 | $128.34 | 3 | Novo Nordisk Inc ($114.81) |
| 2020 | $246.32 | 13 | Novo Nordisk Inc ($44.88) |
| 2019 | $497.11 | 7 | Novo Nordisk Inc ($256.21) |
| 2018 | $25.62 | 2 | Merck Sharp & Dohme Corporation ($13.94) |
| 2017 | $51.62 | 3 | Valeant Pharmaceuticals North America LLC ($24.07) |
All Payment Transactions
342 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $41.68 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 12/12/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $32.64 | General |
| Category: Bone Health | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Cardio-renal | ||||||
| 12/04/2024 | RGH Enterprises LLC | — | Food and Beverage | In-kind items and services | $21.50 | General |
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.41 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/07/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $26.00 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: DIABETES | ||||||
| 10/30/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $32.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/29/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/24/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Bone Health | ||||||
| 10/18/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $39.75 | General |
| Category: Automated insulin delivery system | ||||||
| 10/14/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: Rare Disease | ||||||
| 10/09/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $98.71 | General |
| Category: Endocrinology | ||||||
| 10/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $30.35 | General |
| Category: Bone Health | ||||||
| 09/30/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $36.21 | General |
| Category: Endocrinology | ||||||
| 09/19/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $27.22 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 929 | 43,462 | $1.9M | $528,259 |
| 2022 | 5 | 242 | 303 | $167,456 | $43,032 |
Total Patients
1,171
Total Services
43,765
Medicare Billing
$571,291
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 35 | 36,960 | $1.1M | $296,378 | 26.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 62 | 5,100 | $234,600 | $94,005 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 258 | 485 | $223,100 | $55,077 | 24.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 196 | 196 | $114,660 | $28,216 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 209 | $67,925 | $17,573 | 25.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 81 | 93 | $59,055 | $14,565 | 24.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 73 | 73 | $56,210 | $13,975 | 24.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 93 | 264 | $15,995 | $3,633 | 22.7% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 18 | 20 | $4,720 | $3,094 | 65.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 26 | 62 | $8,866 | $1,743 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 111 | $51,060 | $12,998 | 25.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 60 | 60 | $46,200 | $11,969 | 25.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 44 | 54 | $34,290 | $8,913 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $32,760 | $8,524 | 26.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 11 | 22 | $3,146 | $628.26 | 20.0% |
About Dr. Ali Hamraz, MD
Dr. Ali Hamraz, MD is a Internal Medicine healthcare provider based in Walnut Creek, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2011. The National Provider Identifier (NPI) number assigned to this provider is 1083901961.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ali Hamraz, MD has received a total of $8,355 in payments from pharmaceutical and medical device companies, with $2,440 received in 2024. These payments were reported across 342 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($8,348).
As a Medicare-enrolled provider, Hamraz has provided services to 1,171 Medicare beneficiaries, totaling 43,765 services with total Medicare billing of $571,291. Data is available for 2 years (2022–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Walnut Creek, CA
- Active Since 06/29/2011
- Last Updated 01/07/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083901961
Products in Payments
- Kerendia (Drug) $878.42
- EVENITY (Biological) $827.29
- Ozempic (Drug) $770.98
- Korlym (Drug) $607.41
- JARDIANCE (Drug) $544.69
- Tymlos (Drug) $402.60
- AFREZZA (Drug) $343.30
- iLet Bionic Pancreas (Device) $267.66
- XYOSTED (Drug) $259.65
- Tymlos (Biological) $190.31
- TRULICITY (Drug) $169.64
- MOUNJARO (Drug) $150.97
- Tlando (Drug) $132.00
- Rybelsus (Drug) $124.38
- Tirosint (Drug) $116.38
- TOUJEO (Biological) $114.58
- NOCDURNA (Drug) $110.22
- Prolia (Biological) $109.44
- SYNTHROID (Drug) $104.08
- SIGNIFOR LAR (Drug) $103.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Walnut Creek
Anthony Padula, M.d, M.D
Internal Medicine — Payments: $804,141
Internal Medicine $804,141
Dr. Richard Chang, M.d, M.D
Internal Medicine — Payments: $295,804
Internal Medicine $295,804
Dr. Neal White, Md, MD
Internal Medicine — Payments: $224,225
Internal Medicine $224,225
Dr. Aditi Choudhry, M.d, M.D
Internal Medicine — Payments: $69,819
Internal Medicine $69,819
Dr. Andrew Dublin, Md, MD
Internal Medicine — Payments: $65,190
Internal Medicine $65,190
Dr. Bhavna Malik, Md, MD
Internal Medicine — Payments: $39,855
Internal Medicine $39,855